Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Organ, Tissue, Regeneration, Repair (OTRR) is an emerging biotechnology company focused on developing advanced regenerative medicine solutions for complex tissue repair. The company utilizes a proprietary bio-active scaffold platform designed to mimic the natural extracellular matrix, promoting endogenous cellular recruitment and tissue integration. Their primary research efforts target chronic wound healing and vascular regeneration, specifically addressing high-need areas such as critical limb ischemia and diabetic foot ulcers. By combining stem cell biology with innovative material science, OTRR aims to provide next-generation therapies that restore functional tissue rather than merely providing symptomatic relief.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Organ, Tissue, Regeneration, Repair.